Growth Metrics

OmniAb (OABI) Receivables - Other (2023 - 2026)

OmniAb (OABI) reported Receivables - Other of $3.5 million for Q1 2026, up 400.0% year-over-year from $700000.0 in Q1 2025, and up 337.5% on a QoQ basis from $800000.0 in Q4 2025.

OmniAb (OABI) has 4 years of Receivables - Other data on file, last reported at $3.5 million in Q1 2026.

  • Quarterly Receivables - Other rose 400.0% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 400.0% YoY) and the FY2025 annual result came in at $800000.0, down 69.23% from the prior year.
  • Receivables - Other climbed to $3.5 million in Q1 2026 per OABI's latest filing, from $800000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $3.5 million in Q1 2026 and bottomed at $300000.0 in Q3 2025.
  • The 4-year median for Receivables - Other is $800000.0 (2023), against an average of $1.3 million.
  • The widest annual swing landed in 2025, when Receivables - Other tumbled 69.23%; it then soared 400.0% in 2026.
  • Tracing OABI's Receivables - Other over 4 years: stood at $800000.0 in 2023, then jumped by 225.0% to $2.6 million in 2024, then plunged by 69.23% to $800000.0 in 2025, then jumped by 337.5% to $3.5 million in 2026.
  • Per Business Quant, the three latest OABI Receivables - Other figures stand at $3.5 million (Q1 2026), $800000.0 (Q4 2025), and $300000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.50 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 2.60 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2023 800,000.00
Dec 31, 2023 800,000.00